Doctor profile · Federal record
Dr. MARIA ESCOBAR VASCO, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Internal Medicine Physician · SAN ANTONIO, TX
- NPI 1477818466
- Accepts Medicare
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8300 FLOYD CURL DR
SAN ANTONIO, TX 782293931
(210) 450-9000 - Mailing address
-
7703 FLOYD CURL DR
SAN ANTONIO, TX 782293901
Credentials & registration
- NPI registered
- July 2012 — 14 yrs on file
- Profile last updated
- September 28, 2022
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Texas #R2094
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477818466. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
439
Distinct HCPCS
7
Medicare allowed
$38,884
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 148 | 93 | $119 | |
82947 |
Blood glucose (sugar) level | 76 | 50 | $4 | |
83036 |
Hemoglobin a1c level | 66 | 52 | $9 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 59 | 52 | $171 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 43 | 27 | $33 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 28 | 28 | $211 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 19 | 19 | $158 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 295. This provider delivers 1.5× the peer median.Open Payments
Industry payments received
All-time total
$743
Transactions
14
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 2 | $213.49 | |
| Abbott Laboratories | 3 | $179.71 | |
| Novo Nordisk Inc | 4 | $165.57 | |
| Corcept Therapeutics | 3 | $140.47 | |
| Dexcom, Inc. | 2 | $43.49 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
540
Patients
142
Total drug cost
$519,341
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 86 | 29 | $128,469 |
| Levothyroxine Sodium | Generic | 81 | 28 | $1,131 |
| Trulicity (Dulaglutide) | Brand | 61 | 17 | $102,821 |
| Jardiance (Empagliflozin) | Brand | 56 | 25 | $86,210 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 28 | 0 | $15,499 |
| Hydrocortisone | Generic | 27 | 0 | $522 |
| Tresiba Flextouch U-200 (Insulin Degludec) | Brand | 26 | 0 | $26,648 |
| Mounjaro (Tirzepatide) | Brand | 24 | 0 | $26,086 |
| Novolog Flexpen (Insulin Aspart) | Brand | 24 | 0 | $33,095 |
| Pioglitazone Hcl | Generic | 24 | 15 | $484 |